Science Explorer Back to mapMap
Discussion
Researcher · Genmab (United States) · United States

Suzana S. Couto

Suzana S. Couto publishes mostly in Molecular Biology, Oncology and Hematology, on topics such as Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0001-6932-5442 OpenAlex
World rank
#359,205
of 7,710,434 ranked researchers
Rank in United States
#128,547
of 1,627,098
Works
140
Citations
4.4k
Citations per work
31.2
h-index
33
i10-index 50Top 12% in Molecular Biology
Suzana S. Couto

What does Suzana S. Couto research?

Suzana S. Couto's work is mostly in Medicine (34%), Biochemistry, Genetics and Molecular Biology (31%), Immunology and Microbiology (7%).

Life Sciences: 53 works · 37.5% of their workBiochemistry, Genetics and Molecular Biology: 43 works · 30.7% of their workMolecular Biology: 36 works · 25.8% of their workCancer Research: 7 works · 4.9% of their workImmunology and Microbiology: 10 works · 6.8% of their workImmunology: 10 works · 6.8% of their workHealth Sciences: 48 works · 34.4% of their workMedicine: 48 works · 34.4% of their workOncology: 24 works · 17.4% of their workHematology: 15 works · 10.6% of their workPulmonary and Respiratory Medicine: 9 works · 6.4% of their workEverything else: 39 works · 28.1% of their workTHEIR WORKSuzana S. Couto140works
Life Sciences38%Health Sciences34%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4330.7%
    2. Immunology and Microbiology106.8%
    1. Medicine4834.4%
  3. Everything else3928.1%
  1. 1Molecular Biology26% of their works
  2. 2Oncology17% of their works
  3. 3Hematology11% of their works
  4. 4Immunology7% of their works
  5. 5Pulmonary and Respiratory Medicine6% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Suzana S. Couto's research?

The keywords of their largest research topics: BET Bromodomains, PROTACs, Diagnosis Criteria, International Myeloma Working Group, Lymphoma, Rituximab, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. BET Bromodomains251 topic
  2. PROTACs251 topic
  3. Diagnosis Criteria241 topic
  4. International Myeloma Working Group241 topic
  5. Lymphoma202 topics
  6. Rituximab172 topics
  7. CAR T Cells101 topic
  8. Chimeric Antigen Receptor101 topic
  9. Classification101 topic
  10. Immune Checkpoint Blockade101 topic
  11. Molecular Profiling101 topic
  12. PD-1 and PD-L1101 topic
  13. Cancer Genomics91 topic
  14. Mutational Signatures91 topic
  15. HDAC Inhibitors81 topic
  16. Histone Deacetylases81 topic
  17. Chronic Lymphocytic Leukemia71 topic
  18. Genomic Aberrations71 topic

Where does Suzana S. Couto work?

Suzana S. Couto's main affiliation in the publication record is Genmab (United States), United States.

How many publications and citations does Suzana S. Couto have?

OpenAlex counts 140 works and 4,363 citations for Suzana S. Couto, an h-index of 33, ranking #359,205 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Suzana S. Couto. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.